TrialThe Journal of infectious diseases2025

A Phase 2b Trial Evaluating the Safety, Tolerability, and Immunogenicity of a 6-Valent Group B Streptococcus Vaccine Administered Concomitantly With Tetanus, Diphtheria, and Acellular Pertussis Vaccine in Healthy Nonpregnant Female Individuals.

William B Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.